‹
›
This content requires a premium subscription.
Please
log in
or
subscribe
to continue.
JAMA Oncology Author Interviews
Survival and Adjuvant Chemotherapy in Early-Stage NSCLC With vs Without Clinicopathologic Features
30
00:00:00
/ 00:23:11
30